As of 2025-09-16, the Relative Valuation of Bristol-Myers Squibb Co (BMY) is 60.10 USD. This relative valuation is based on P/E multiples. With the latest stock price at 46.35 USD, the upside of Bristol-Myers Squibb Co based on Relative Valuation is 29.7%.
The range of the Relative Valuation is 45.20 - 94.68 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.4x - 38.2x | 28.7x |
| Forward P/E multiples | 18.2x - 22.2x | 19.8x |
| Fair Price | 45.20 - 94.68 | 60.10 |
| Upside | -2.5% - 104.3% | 29.7% |
| Date | P/E |
| 2025-09-15 | 18.68 |
| 2025-09-12 | 18.62 |
| 2025-09-11 | 19.16 |
| 2025-09-10 | 19.00 |
| 2025-09-09 | 19.04 |
| 2025-09-08 | 18.83 |
| 2025-09-05 | 19.00 |
| 2025-09-04 | 18.82 |
| 2025-09-03 | 19.15 |
| 2025-09-02 | 19.11 |
| 2025-08-29 | 19.02 |
| 2025-08-28 | 18.90 |
| 2025-08-27 | 19.20 |
| 2025-08-26 | 19.03 |
| 2025-08-25 | 19.00 |
| 2025-08-22 | 19.31 |
| 2025-08-21 | 19.52 |
| 2025-08-20 | 19.45 |
| 2025-08-19 | 19.48 |
| 2025-08-18 | 19.42 |
| 2025-08-15 | 19.52 |
| 2025-08-14 | 19.27 |
| 2025-08-13 | 19.29 |
| 2025-08-12 | 18.76 |
| 2025-08-11 | 18.51 |
| 2025-08-08 | 18.52 |
| 2025-08-07 | 18.28 |
| 2025-08-06 | 18.07 |
| 2025-08-05 | 18.48 |
| 2025-08-04 | 18.30 |
| 2025-08-01 | 17.83 |
| 2025-07-31 | 17.46 |
| 2025-07-30 | 18.53 |
| 2025-07-29 | 18.89 |
| 2025-07-28 | 19.15 |
| 2025-07-25 | 19.52 |
| 2025-07-24 | 19.73 |
| 2025-07-23 | 19.74 |
| 2025-07-22 | 19.35 |
| 2025-07-21 | 18.82 |
| 2025-07-18 | 19.09 |
| 2025-07-17 | 19.37 |
| 2025-07-16 | 19.01 |
| 2025-07-15 | 18.71 |
| 2025-07-14 | 19.08 |
| 2025-07-11 | 18.89 |
| 2025-07-10 | 19.56 |
| 2025-07-09 | 19.21 |
| 2025-07-08 | 18.96 |
| 2025-07-07 | 18.74 |